Overview
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
Status:
Completed
Completed
Trial end date:
2014-07-01
2014-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Purpose: This study is a Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb(wrist, finger, elbow, thumb)Spasticity.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA
Criteria
Inclusion Criteria:1. Male or female adult patients
2. ≥ 6 weeks since the last stroke
Exclusion Criteria:
1.Patients with diagnosed neuromuscular disorders such as Lamber-Eaton syndrome, myasthenia
gravis, or amyotrophic lateral sclerosis.